Zephyrnet Logo

Tag: roche

How to easily do Handwriting Recognition using Deep Learning

Want to OCR handwritten forms? This blog is a comprehensive overview of the latest methods of handwriting recognition using deep learning. We've reviewed...

Data-driven innovation in healthcare: synthetical clinical data

This articles discusses some of the data challenges that the healthcare industry faces. It also revisits how Statice's collaboration with the leading health...

Opdivo trial offers new insights into how immuno-oncology drugs could be enhanced

Despite the success of checkpoint inhibitors that remove the blockade that cancer cells impose on the immune system, the drugs only work in...

Roche nets FDA authorization for combination COVID-19 and flu test

Roche announced the launch of its second COVID-19 diagnostic of the week after securing an FDA authorization for a test that detects the...

Roche to launch 40M rapid coronavirus antigen tests per month, starting in Europe

Roche plans to make a rapid antigen test for the novel coronavirus widely available in Europe later this month, while also submitting it...

BMS oncology chief Namouni lands at Blueprint Medicines to lead R&D

As Blueprint Medicines preps for the U.S. and EU approvals of its RET inhibitor, the company is bringing its research and clinical development...

Introducing SubRecs: an engine that recommends Subreddit communities based on your personality.

Try SubRecs yourself at SubRecs.app.There are 183,000 communities — also know as subreddits — on Reddit. An intimidating number to say the least....

ILC: Searching for a functional cure while battling rivals, Vir and Alnylam post hep B data peek

The battle to be the first RNAi to help cure hepatitis B is heating up as Vir Biotechnology and partner Alnylam release ongoing...

Foundation Medicine’s cancer-profiling blood test approved by FDA

The FDA has approved Foundation Medicine’s liquid biopsy blood test, allowing oncologists to profile the genomic mutations found within any solid tumor without...

ILC: J&J’s RNAi suppresses hepatitis B for 48 weeks after last dose

Johnson & Johnson has presented clinical trial data linking short-term treatment with RNAi therapy JNJ-3989 to sustained reductions in markers of hepatitis B...

Freenome secures $270M to boost its colorectal cancer blood test, expand trial nationwide

Freenome continues to draw strong financial support for its development work, with $270 million in new funds to push its cancer-detecting blood test...

Trump administration revokes FDA authority over lab-developed tests, including some COVID-19 diagnostics

The Trump administration has revoked the FDA’s authority over lab-developed tests, including requirements that certain diagnostics made for COVID-19 go through the agency’s...

Latest Intelligence

spot_img
spot_img

Chat with us

Hi there! How can I help you?